Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lancaster

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
British Journal of Cancer|December 4, 1998
BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1J M Lancaster, M E Carney, J Gray, et al.
Clinical Genetics|February 27, 2013
Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriersT Pal, J-H Lee, A Besharat, et al.
Oncogene|January 29, 2013
Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancerW Kong, L He, E J Richards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Frequency of germline and somatic BRCA1 mutations in ovarian cancerA Berchuck, K A Heron, M E Carney, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Identification of genes associated with ovarian cancer metastasis using microarray expression analysisJ M Lancaster, H K Dressman, J P Clarke, et al.
British Journal of Cancer|May 19, 2012
In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survivalE Bicaku, Y Xiong, D C Marchion, et al.
Nature Genetics|May 1, 1996
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer familiesC M Phelan, J M Lancaster, P Tonin, et al.
Nature Genetics|June 1, 1996
BRCA2 mutations in primary breast and ovarian cancersJ M Lancaster, R Wooster, J Mangion, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
British Journal of Cancer|December 4, 1998
BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1J M Lancaster, M E Carney, J Gray, et al.
Clinical Genetics|February 27, 2013
Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriersT Pal, J-H Lee, A Besharat, et al.
Oncogene|January 29, 2013
Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancerW Kong, L He, E J Richards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Frequency of germline and somatic BRCA1 mutations in ovarian cancerA Berchuck, K A Heron, M E Carney, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Identification of genes associated with ovarian cancer metastasis using microarray expression analysisJ M Lancaster, H K Dressman, J P Clarke, et al.
British Journal of Cancer|May 19, 2012
In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survivalE Bicaku, Y Xiong, D C Marchion, et al.
Nature Genetics|May 1, 1996
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer familiesC M Phelan, J M Lancaster, P Tonin, et al.
Nature Genetics|June 1, 1996
BRCA2 mutations in primary breast and ovarian cancersJ M Lancaster, R Wooster, J Mangion, et al.
Pageof 3